Stress Ulcer Prophylaxis in Critically Ill Patients
For critically ill patients with risk factors for gastrointestinal bleeding, stress ulcer prophylaxis should be provided using either proton pump inhibitors (PPIs) or histamine-2 receptor antagonists (H2RAs), and should be discontinued when risk factors are no longer present. 1
Risk Factors for Stress-Related GI Bleeding
The most important risk factors that warrant stress ulcer prophylaxis include:
- Mechanical ventilation for >48 hours 1
- Coagulopathy (including therapeutic anticoagulation, thrombocytopenia, or other clotting disorders) 1
- Shock (especially septic shock) 1, 2
- Chronic liver disease 1
Recommended Prophylaxis Approach
First-Line Agents
- Either PPIs or H2RAs are appropriate first-line agents 1
- No significant difference in mortality has been demonstrated between these agents 3
- Low-dose therapy is sufficient and preferred over high-dose regimens 1
Route of Administration
- Both enteral and intravenous routes are acceptable 1
- For patients who can tolerate enteral medications, the enteral route may be preferred due to lower cost
Duration of Therapy
- Continue prophylaxis only while risk factors are present 1
- Discontinue prophylaxis before ICU discharge to prevent inappropriate continuation 1
Special Considerations
Enteral Nutrition
- Enteral nutrition itself provides some protection against stress ulcers 1
- However, patients with risk factors should still receive pharmacologic prophylaxis even when enterally fed 1
- Patients without risk factors who are enterally fed do not require prophylaxis 1
Potential Adverse Effects
- PPIs and H2RAs may increase risk of:
Pre-existing Acid Suppression Therapy
- For patients already on acid suppression therapy before ICU admission:
Implementation Algorithm
Assess risk factors on ICU admission:
- Mechanical ventilation expected >48 hours?
- Coagulopathy present?
- Shock present?
- Chronic liver disease?
If risk factors present:
- Start either PPI (e.g., pantoprazole 40mg daily) or H2RA (e.g., famotidine 20mg daily)
- Use enteral route if possible, IV if necessary
If no risk factors present:
- Do not initiate prophylaxis
- If patient already on acid-suppression therapy, consider discontinuation
Daily reassessment:
- Continue to evaluate presence of risk factors
- Discontinue prophylaxis when risk factors resolve
- Ensure prophylaxis is discontinued before ICU transfer
By following this evidence-based approach, clinicians can provide appropriate stress ulcer prophylaxis to critically ill patients who need it while avoiding unnecessary medication exposure in those who don't.